EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ferroptosis Induction by Fenbendazole Combined With Photothermal Therapy Triggers Dual‐Immunotherapy Against Bladder Cancer

Xiaojian Xu, Rui Liang, Anguo Zhao, Jun Zhang iD, Rongkang Li, Yang Liu, Dashi Deng, Qi Zhuang, Lisha Liu, Lei Peng, Miao Li iD, Xuedong Wei und 4 weitere

Advanced Science · 2026-06 · 13 (31)

DOI: 10.1002/advs.74876 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 20.03.2026. Verfasst von Xiaojian Xu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou, China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Ferroptosis, Photothermal Therapy, Immunotherapy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Soochow Youth Science and Technology Project of "Science and Education Prosper Health, National Natural Science Foundation of China, Shenzhen Engineering Research Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ferroptosis, a newly recognized form of regulated cell death, has emerged as a promising strategy in cancer therapy. Given the high incidence and recurrence rates of bladder cancer, exploring novel therapeutic approaches is critically important. In this study, we developed a novel intravesical nanoplatform, FBZ@BSA@PDA, that integrates ferroptosis‐related oxidative injury immunogenic cell death (ICD) activation, and photothermal therapy (PTT) to achieve synergistic treatment of bladder cancer. The hydrophobic drug fenbendazole (FBZ) was efficiently encapsulated via thermally induced unfolding of bovine serum albumin (BSA), and polydopamine (PDA) was formed by in situ polymerization of dopamine to enhance tissue adhesion and photothermal responsiveness. Following transurethral intravesical administration, the platform enabled sustained drug release and localized PTT. Mechanistically, it induced lipid peroxidation (LPO), GSH depletion, and mitochondrial dysfunction, which suggest that ferroptosis may contribute to tumor cell death. This was accompanied by key ICD markers, including calreticulin (CRT) exposure, high mobility group box 1 (HMGB1) release, and adenosine triphosphate (ATP) secretion, which effectively promoted dendritic cell (DC) maturation and T‐cell activation. FBZ@BSA@PDA demonstrated strong anti‐tumor efficacy and favorable biosafety in an orthotopic mouse model of bladder cancer. This strategy offers a promising localized immune‐potentiated therapeutic approach for clinical bladder cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsFerroptosisPhotothermal TherapyImmunotherapyAnimalsMiceHumansIndolesCell Line, TumorPolymersFemale

Stichwörter der Autor:innen

bladder cancerferroptosisflubendazolephotothermal therapypolydopamine

Substanzen

IndolesPolymerspolydopamine

Autor:innen und Institutionen

  • Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Department of Urology, South China Hospital, Medical School, Shenzhen University, Shenzhen, China.
  • Department of Urology, The Fourth Affiliated Hospital of Soochow University, Medical Center of Soochow University, Suzhou Dushu Lake Hospital, Suzhou, China.
  • Department of Urology, The Affiliated Luohu Hospital of Shenzhen University, Shenzhen University, Shenzhen, China.
  • Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon Based Functional Materials & Devices, Soochow University, Shenzhen, China.

ORCID-Profile: Jun Zhang, Miao Li, Liang Cheng

Förderung

  • Soochow Youth Science and Technology Project of "Science and Education Prosper Health
  • National Natural Science Foundation of China
  • Shenzhen Engineering Research Center
  • Sanming Project of Medicine in Shenzhen

Zitieren

APA

Xu, X., Liang, R., Zhao, A., Zhang, J., Li, R., Liu, Y., Deng, D., Zhuang, Q., Liu, L., Peng, L., Li, M., Wei, X., Huang, Y., Zhang, S., Cheng, L., & Hou, J. (2026). Ferroptosis Induction by Fenbendazole Combined With Photothermal Therapy Triggers Dual‐Immunotherapy Against Bladder Cancer. Advanced Science, 13(31). https://doi.org/10.1002/advs.74876

Vancouver

Xu X, Liang R, Zhao A, Zhang J, Li R, Liu Y, et al. Ferroptosis Induction by Fenbendazole Combined With Photothermal Therapy Triggers Dual‐Immunotherapy Against Bladder Cancer. Advanced Science. 2026;13(31). doi:10.1002/advs.74876

BibTeX
@article{Xu2026,
  author = {Xu, Xiaojian and Liang, Rui and Zhao, Anguo and Zhang, Jun and Li, Rongkang and Liu, Yang and Deng, Dashi and Zhuang, Qi and Liu, Lisha and Peng, Lei and Li, Miao and Wei, Xuedong and Huang, Yuhua and Zhang, Shaohua and Cheng, Liang and Hou, Jianquan},
  title = {Ferroptosis Induction by Fenbendazole Combined With Photothermal Therapy Triggers Dual‐Immunotherapy Against Bladder Cancer},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {31},
  doi = {10.1002/advs.74876}
}
Kostenlos starten →